Parkinson's disease is the second most common neurodegenerative disease, after Alzheimer's disease. Current research is still unable to deeply analyze the occurrence and progression of Parkinson's disease.
Metabolomics analysis has broad prospects in the study of pathogenesis, and provides important information for finding methods for clinical diagnosis and disease treatment of Parkinson's disease.
Proteomics is the analysis of dynamic protein composition, expression level and modification state in cells (or tissues, etc.) from an overall perspective. It is an effective method for exploring disease pathogenesis, disease diagnosis and drug treatment. Proteomics research on Parkinson's disease can provide a strong basis for revealing the pathogenesis of PD, diagnostic markers and finding new drug targets at the protein level.
Live preview
April 11 (World Parkinson's Disease Day) 14:00
Aqu Class will share with you how metabolomics and proteomics can help Parkinson's disease research
Direct link: https://fs80.cn/fk18vs
